XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)        
Collaboration revenue $ 41,086 $ 1,482 $ 42,457 $ 9,342
Operating expenses:        
Research and development 19,337 17,914 46,213 59,767
General and administrative 7,307 8,714 22,518 28,895
Total operating expenses 26,644 26,628 68,731 88,662
Operating income (loss) 14,442 (25,146) (26,274) (79,320)
Other income, net:        
Interest income 545 121 816 253
Other income (expensive) 2,637 (112) 2,676 2,161
Total other income, net 3,182 9 3,492 2,414
Net income (loss) 17,624 (25,137) (22,782) (76,906)
Other comprehensive income (loss)        
Net unrealized (loss) gain on available-for-sale securities 27 (2) (199) 6
Total other comprehensive income (loss) 27 (2) (199) 6
Comprehensive income (loss) $ 17,651 $ (25,139) $ (22,981) $ (76,900)
Net income (loss) per share, basic $ 0.46 $ (0.67) $ (0.59) $ (2.04)
Net income (loss) per share, diluted $ 0.45 $ (0.67) $ (0.59) $ (2.04)
Weighted-average common shares outstanding, basic 38,507,542 37,780,547 38,292,497 37,623,309
Weighted-average common shares outstanding, diluted 39,570,394 37,780,547 38,292,497 37,623,309